ProfileGDS5822 / ILMN_2495703
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 83% 80% 73% 83% 81% 79% 89% 82% 79% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1207.583
GSM1276600PDAC Late Ablation Control 215280
GSM1276601PDAC Late Ablation Control 3101.573
GSM1276602PDAC Late Ablation 1190.183
GSM1276603PDAC Late Ablation 2175.881
GSM1276604PDAC Late Ablation 3141.979
GSM1303940PDAC Late Ablation_anti-CTLA4 1402.289
GSM1303941PDAC Late Ablation_anti-CTLA4 2217.882
GSM1303942PDAC Late Ablation_anti-CTLA4 3171.779